Hui Shi

9.9k total citations · 8 hit papers
98 papers, 7.7k citations indexed

About

Hui Shi is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Hui Shi has authored 98 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 25 papers in Cancer Research and 13 papers in Surgery. Recurrent topics in Hui Shi's work include Extracellular vesicles in disease (27 papers), MicroRNA in disease regulation (18 papers) and Cancer-related molecular mechanisms research (11 papers). Hui Shi is often cited by papers focused on Extracellular vesicles in disease (27 papers), MicroRNA in disease regulation (18 papers) and Cancer-related molecular mechanisms research (11 papers). Hui Shi collaborates with scholars based in China, Singapore and United States. Hui Shi's co-authors include Hui Qian, Wenrong Xu, Xu Zhang, Bin Zhang, Lijun Wu, Xiao Yuan, Chwee Teck Lim, Kian Ping Loh, Wong Cheng Lee and Yu Wang and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Hui Shi

97 papers receiving 7.6k citations

Hit Papers

Origin of Enhanced Stem Cell Growth and Differentiation o... 2011 2026 2016 2021 2011 2015 2014 2018 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Origin of Enhanced Stem Cell Growth and Differentiation on Graphene and Graphene Oxide
    2011 895 citations Hui Shi et al. ACS Nano profile →
  2. Exosomes in cancer: small particle, big player
    2015 633 citations Xu Zhang, Hui Shi et al. profile →
  3. HucMSC-Exosome Mediated-Wnt4 Signaling Is Required for Cutaneous Wound Healing
    2014 632 citations Bin Zhang, Xu Zhang et al. profile →
  4. Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction
    2018 354 citations Yaoxiang Sun, Hui Shi et al. ACS Nano profile →
  5. Engineered Extracellular Vesicles for Cancer Therapy
    2021 342 citations Xu Zhang, Jianmei Gu et al. profile →
  6. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
    2021 231 citations Runping Fang, Hui Shi et al. Nature Communications profile →
  7. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy
    2022 209 citations Cheng Ji, Hui Shi et al. profile →
  8. Tailoring traditional Chinese medicine in cancer therapy
    2025 33 citations Xi Chen, Hui Shi et al. Molecular Cancer profile →

Peers

Hui Shi
Xiaoxiao Cai China
Zongjin Li China
Sung‐Hwan Moon South Korea
Shiwu Dong China
Xu Zhang China
Cun‐Yu Wang United States
Masoud Soleimani Iran
Olivier De Wever Belgium
Chun‐Yuan Chen China
Xiaoxiao Cai China
Hui Shi
Citations per year, relative to Hui Shi Hui Shi (= 1×) peers Xiaoxiao Cai

Countries citing papers authored by Hui Shi

Since Specialization
Citations

This map shows the geographic impact of Hui Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Shi more than expected).

Fields of papers citing papers by Hui Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Shi. The network helps show where Hui Shi may publish in the future.

Co-authorship network of co-authors of Hui Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Shi. A scholar is included among the top collaborators of Hui Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Shi. Hui Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Hui, Rong Gao, Wei Zhang, et al.. (2025). Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma. Nature Communications. 16(1). 11034–11034.
2.
Chen, Xi, et al.. (2025). Tailoring traditional Chinese medicine in cancer therapy. Molecular Cancer. 24(1). 27–27. 33 indexed citations breakdown →
3.
Ji, Cheng, et al.. (2024). Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis. npj Regenerative Medicine. 9(1). 3–3. 16 indexed citations
4.
Zheng, Tong, Yu Bai, Entao Li, et al.. (2024). The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association. Journal of Virology. 98(4). e0156523–e0156523. 2 indexed citations
5.
6.
Li, Jingyao, et al.. (2023). Tailored biomedical materials for wound healing. Burns & Trauma. 11. tkad040–tkad040. 23 indexed citations
7.
Xu, Jing, Jianmei Gu, Hui Shi, et al.. (2022). Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. Advanced Science. 9(34). e2201609–e2201609. 97 indexed citations
8.
Wang, Min, Peipei Wu, Wenhui Liu, et al.. (2022). Skin cell-derived extracellular vesicles: a promising therapeutic strategy for cutaneous injury. Burns & Trauma. 10. tkac037–tkac037. 20 indexed citations
9.
Shi, Hui, Min Wang, Yaoxiang Sun, et al.. (2021). Exosomes: Emerging Cell-Free Based Therapeutics in Dermatologic Diseases. Frontiers in Cell and Developmental Biology. 9. 736022–736022. 37 indexed citations
10.
Shi, Ying‐Hong, et al.. (2019). Mesenchymal stem cell–derived extracellular vesicles: a new impetus of promoting angiogenesis in tissue regeneration. Cytotherapy. 21(5). 497–508. 52 indexed citations
11.
Zhang, Bin, Hui Shi, Rong Li, et al.. (2019). The Role of CDR1as in Proliferation and Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells. Stem Cells International. 2019. 1–11. 26 indexed citations
12.
Fu, Jia, Guanjun Dong, Hui Shi, et al.. (2019). LncRNA MIR503HG inhibits cell migration and invasion via miR‐103/OLFM4 axis in triple negative breast cancer. Journal of Cellular and Molecular Medicine. 23(7). 4738–4745. 44 indexed citations
13.
14.
Sun, Yaoxiang, Hui Shi, Siqi Yin, et al.. (2018). Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction. ACS Nano. 12(8). 7613–7628. 354 indexed citations breakdown →
15.
Zhang, Rongxue, Lei Yin, Bin Zhang, et al.. (2018). Resveratrol improves human umbilical cord-derived mesenchymal stem cells repair for cisplatin-induced acute kidney injury. Cell Death and Disease. 9(10). 965–965. 42 indexed citations
16.
Li, Yinghui, Zhen Wang, Hui Shi, et al.. (2016). HBXIP and LSD1 Scaffolded by lncRNA Hotair Mediate Transcriptional Activation by c-Myc. Cancer Research. 76(2). 293–304. 110 indexed citations
17.
Zhang, Bin, Li Shen, Hui Shi, et al.. (2016). Exosomes from Human Umbilical Cord Mesenchymal Stem Cells: Identification, Purification, and Biological Characteristics. Stem Cells International. 2016(1). 1929536–1929536. 102 indexed citations
18.
19.
Shi, Hui, Min‐Cheol Kim, Dong‐An Wang, et al.. (2014). Quantification of Magnetically Induced Changes in ECM Local Apparent Stiffness. Biophysical Journal. 106(1). 332–341. 9 indexed citations
20.
Li, Yinghui, Zhao Zhang, Xiaolei Zhou, et al.. (2014). The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling. Cancer Letters. 355(2). 288–296. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoxiao Cai Breakdown of academic impact, for papers by Zongjin Li Breakdown of academic impact, for papers by Sung‐Hwan Moon Breakdown of academic impact, for papers by Shiwu Dong Breakdown of academic impact, for papers by Xu Zhang Breakdown of academic impact, for papers by Cun‐Yu Wang Breakdown of academic impact, for papers by Masoud Soleimani Breakdown of academic impact, for papers by Olivier De Wever Breakdown of academic impact, for papers by Chun‐Yuan Chen
Rankless by CCL
2026